nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—BCHE—Irinotecan—pancreatic cancer	0.232	0.376	CbGbCtD
Nizatidine—HRH2—gastric juice—pancreatic cancer	0.0781	0.88	CbGeAlD
Nizatidine—ABCB1—Tamoxifen—pancreatic cancer	0.0768	0.124	CbGbCtD
Nizatidine—ABCB1—Gemcitabine—pancreatic cancer	0.0662	0.107	CbGbCtD
Nizatidine—ABCB1—Erlotinib—pancreatic cancer	0.0653	0.106	CbGbCtD
Nizatidine—ABCB1—Irinotecan—pancreatic cancer	0.059	0.0954	CbGbCtD
Nizatidine—ABCB1—Docetaxel—pancreatic cancer	0.0432	0.0699	CbGbCtD
Nizatidine—ABCB1—Sunitinib—pancreatic cancer	0.043	0.0696	CbGbCtD
Nizatidine—ABCB1—Doxorubicin—pancreatic cancer	0.0322	0.0521	CbGbCtD
Nizatidine—HRH2—digestive system—pancreatic cancer	0.00476	0.0537	CbGeAlD
Nizatidine—BCHE—digestive system—pancreatic cancer	0.00208	0.0234	CbGeAlD
Nizatidine—ABCB1—islet of Langerhans—pancreatic cancer	0.00165	0.0186	CbGeAlD
Nizatidine—ABCB1—pancreas—pancreatic cancer	0.00116	0.0131	CbGeAlD
Nizatidine—ABCB1—digestive system—pancreatic cancer	0.000989	0.0112	CbGeAlD
Nizatidine—Insomnia—Sunitinib—pancreatic cancer	0.000648	0.00316	CcSEcCtD
Nizatidine—Pneumonia—Docetaxel—pancreatic cancer	0.000643	0.00314	CcSEcCtD
Nizatidine—Anaemia—Fluorouracil—pancreatic cancer	0.00064	0.00312	CcSEcCtD
Nizatidine—Cough—Irinotecan—pancreatic cancer	0.000631	0.00308	CcSEcCtD
Nizatidine—Dyspepsia—Sunitinib—pancreatic cancer	0.000631	0.00308	CcSEcCtD
Nizatidine—Jaundice—Docetaxel—pancreatic cancer	0.000623	0.00304	CcSEcCtD
Nizatidine—Decreased appetite—Sunitinib—pancreatic cancer	0.000623	0.00304	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000618	0.00302	CcSEcCtD
Nizatidine—Cough—Gemcitabine—pancreatic cancer	0.000615	0.003	CcSEcCtD
Nizatidine—Constipation—Sunitinib—pancreatic cancer	0.000613	0.00299	CcSEcCtD
Nizatidine—Pain—Sunitinib—pancreatic cancer	0.000613	0.00299	CcSEcCtD
Nizatidine—Asthenia—Tamoxifen—pancreatic cancer	0.0006	0.00293	CcSEcCtD
Nizatidine—Convulsion—Fluorouracil—pancreatic cancer	0.0006	0.00293	CcSEcCtD
Nizatidine—Chest pain—Gemcitabine—pancreatic cancer	0.0006	0.00293	CcSEcCtD
Nizatidine—Myalgia—Gemcitabine—pancreatic cancer	0.0006	0.00293	CcSEcCtD
Nizatidine—Confusional state—Irinotecan—pancreatic cancer	0.000595	0.0029	CcSEcCtD
Nizatidine—Asthenia—Erlotinib—pancreatic cancer	0.000594	0.0029	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000593	0.0029	CcSEcCtD
Nizatidine—Pruritus—Tamoxifen—pancreatic cancer	0.000592	0.00289	CcSEcCtD
Nizatidine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00059	0.00288	CcSEcCtD
Nizatidine—Myalgia—Fluorouracil—pancreatic cancer	0.00059	0.00288	CcSEcCtD
Nizatidine—Chest pain—Fluorouracil—pancreatic cancer	0.00059	0.00288	CcSEcCtD
Nizatidine—Infection—Irinotecan—pancreatic cancer	0.000586	0.00286	CcSEcCtD
Nizatidine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000586	0.00286	CcSEcCtD
Nizatidine—Pruritus—Erlotinib—pancreatic cancer	0.000585	0.00286	CcSEcCtD
Nizatidine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000578	0.00282	CcSEcCtD
Nizatidine—Rhinitis—Docetaxel—pancreatic cancer	0.000576	0.00281	CcSEcCtD
Nizatidine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000575	0.00281	CcSEcCtD
Nizatidine—Hepatitis—Docetaxel—pancreatic cancer	0.000574	0.0028	CcSEcCtD
Nizatidine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000572	0.00279	CcSEcCtD
Nizatidine—Infection—Gemcitabine—pancreatic cancer	0.000571	0.00279	CcSEcCtD
Nizatidine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00057	0.00279	CcSEcCtD
Nizatidine—Confusional state—Fluorouracil—pancreatic cancer	0.00057	0.00278	CcSEcCtD
Nizatidine—Pharyngitis—Docetaxel—pancreatic cancer	0.00057	0.00278	CcSEcCtD
Nizatidine—Body temperature increased—Sunitinib—pancreatic cancer	0.000566	0.00276	CcSEcCtD
Nizatidine—Abdominal pain—Sunitinib—pancreatic cancer	0.000566	0.00276	CcSEcCtD
Nizatidine—Diarrhoea—Erlotinib—pancreatic cancer	0.000566	0.00276	CcSEcCtD
Nizatidine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000565	0.00276	CcSEcCtD
Nizatidine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000563	0.00275	CcSEcCtD
Nizatidine—Anorexia—Irinotecan—pancreatic cancer	0.000562	0.00275	CcSEcCtD
Nizatidine—Infection—Fluorouracil—pancreatic cancer	0.000561	0.00274	CcSEcCtD
Nizatidine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000556	0.00271	CcSEcCtD
Nizatidine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000553	0.0027	CcSEcCtD
Nizatidine—Dizziness—Tamoxifen—pancreatic cancer	0.000553	0.0027	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000549	0.00268	CcSEcCtD
Nizatidine—Anorexia—Gemcitabine—pancreatic cancer	0.000548	0.00268	CcSEcCtD
Nizatidine—Dizziness—Erlotinib—pancreatic cancer	0.000547	0.00267	CcSEcCtD
Nizatidine—Anorexia—Fluorouracil—pancreatic cancer	0.000539	0.00263	CcSEcCtD
Nizatidine—Insomnia—Irinotecan—pancreatic cancer	0.000534	0.00261	CcSEcCtD
Nizatidine—Vomiting—Tamoxifen—pancreatic cancer	0.000532	0.0026	CcSEcCtD
Nizatidine—Rash—Tamoxifen—pancreatic cancer	0.000527	0.00257	CcSEcCtD
Nizatidine—Dermatitis—Tamoxifen—pancreatic cancer	0.000527	0.00257	CcSEcCtD
Nizatidine—Vomiting—Erlotinib—pancreatic cancer	0.000526	0.00257	CcSEcCtD
Nizatidine—Somnolence—Irinotecan—pancreatic cancer	0.000525	0.00256	CcSEcCtD
Nizatidine—Headache—Tamoxifen—pancreatic cancer	0.000524	0.00256	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000524	0.00256	CcSEcCtD
Nizatidine—Rash—Erlotinib—pancreatic cancer	0.000522	0.00255	CcSEcCtD
Nizatidine—Dermatitis—Erlotinib—pancreatic cancer	0.000521	0.00255	CcSEcCtD
Nizatidine—Insomnia—Gemcitabine—pancreatic cancer	0.00052	0.00254	CcSEcCtD
Nizatidine—Dyspepsia—Irinotecan—pancreatic cancer	0.000519	0.00254	CcSEcCtD
Nizatidine—Headache—Erlotinib—pancreatic cancer	0.000518	0.00253	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000515	0.00251	CcSEcCtD
Nizatidine—Asthenia—Sunitinib—pancreatic cancer	0.000514	0.00251	CcSEcCtD
Nizatidine—Decreased appetite—Irinotecan—pancreatic cancer	0.000513	0.0025	CcSEcCtD
Nizatidine—Insomnia—Fluorouracil—pancreatic cancer	0.000511	0.0025	CcSEcCtD
Nizatidine—Somnolence—Gemcitabine—pancreatic cancer	0.000511	0.00249	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000509	0.00249	CcSEcCtD
Nizatidine—Pruritus—Sunitinib—pancreatic cancer	0.000507	0.00247	CcSEcCtD
Nizatidine—Pain—Irinotecan—pancreatic cancer	0.000505	0.00246	CcSEcCtD
Nizatidine—Constipation—Irinotecan—pancreatic cancer	0.000505	0.00246	CcSEcCtD
Nizatidine—Somnolence—Fluorouracil—pancreatic cancer	0.000502	0.00245	CcSEcCtD
Nizatidine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000501	0.00244	CcSEcCtD
Nizatidine—Decreased appetite—Gemcitabine—pancreatic cancer	0.0005	0.00244	CcSEcCtD
Nizatidine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000497	0.00243	CcSEcCtD
Nizatidine—Nausea—Tamoxifen—pancreatic cancer	0.000497	0.00243	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000496	0.00242	CcSEcCtD
Nizatidine—Pain—Gemcitabine—pancreatic cancer	0.000492	0.0024	CcSEcCtD
Nizatidine—Constipation—Gemcitabine—pancreatic cancer	0.000492	0.0024	CcSEcCtD
Nizatidine—Nausea—Erlotinib—pancreatic cancer	0.000492	0.0024	CcSEcCtD
Nizatidine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000491	0.0024	CcSEcCtD
Nizatidine—Diarrhoea—Sunitinib—pancreatic cancer	0.00049	0.00239	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000488	0.00238	CcSEcCtD
Nizatidine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000486	0.00237	CcSEcCtD
Nizatidine—Back pain—Docetaxel—pancreatic cancer	0.000483	0.00236	CcSEcCtD
Nizatidine—Pain—Fluorouracil—pancreatic cancer	0.000483	0.00236	CcSEcCtD
Nizatidine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000482	0.00236	CcSEcCtD
Nizatidine—Eosinophilia—Epirubicin—pancreatic cancer	0.000479	0.00234	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.000477	0.0054	CbGpPWpGaD
Nizatidine—Dizziness—Sunitinib—pancreatic cancer	0.000474	0.00231	CcSEcCtD
Nizatidine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000474	0.00231	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—CCKBR—pancreatic cancer	0.000467	0.00529	CbGpPWpGaD
Nizatidine—Abdominal pain—Irinotecan—pancreatic cancer	0.000466	0.00228	CcSEcCtD
Nizatidine—Body temperature increased—Irinotecan—pancreatic cancer	0.000466	0.00228	CcSEcCtD
Nizatidine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000466	0.00227	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.000464	0.00526	CbGpPWpGaD
Nizatidine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000463	0.00226	CcSEcCtD
Nizatidine—Anaemia—Docetaxel—pancreatic cancer	0.000462	0.00226	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.000457	0.00518	CbGpPWpGaD
Nizatidine—Vomiting—Sunitinib—pancreatic cancer	0.000455	0.00222	CcSEcCtD
Nizatidine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000454	0.00222	CcSEcCtD
Nizatidine—Rash—Sunitinib—pancreatic cancer	0.000452	0.00221	CcSEcCtD
Nizatidine—Dermatitis—Sunitinib—pancreatic cancer	0.000451	0.0022	CcSEcCtD
Nizatidine—Urticaria—Fluorouracil—pancreatic cancer	0.000449	0.00219	CcSEcCtD
Nizatidine—Headache—Sunitinib—pancreatic cancer	0.000449	0.00219	CcSEcCtD
Nizatidine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000447	0.00218	CcSEcCtD
Nizatidine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000443	0.00216	CcSEcCtD
Nizatidine—Cough—Docetaxel—pancreatic cancer	0.000436	0.00213	CcSEcCtD
Nizatidine—Pneumonia—Epirubicin—pancreatic cancer	0.000434	0.00212	CcSEcCtD
Nizatidine—Convulsion—Docetaxel—pancreatic cancer	0.000433	0.00211	CcSEcCtD
Nizatidine—Chest pain—Docetaxel—pancreatic cancer	0.000425	0.00208	CcSEcCtD
Nizatidine—Myalgia—Docetaxel—pancreatic cancer	0.000425	0.00208	CcSEcCtD
Nizatidine—Nausea—Sunitinib—pancreatic cancer	0.000425	0.00208	CcSEcCtD
Nizatidine—Asthenia—Irinotecan—pancreatic cancer	0.000423	0.00207	CcSEcCtD
Nizatidine—Jaundice—Epirubicin—pancreatic cancer	0.00042	0.00205	CcSEcCtD
Nizatidine—Dry mouth—Docetaxel—pancreatic cancer	0.000416	0.00203	CcSEcCtD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000416	0.00471	CbGpPWpGaD
Nizatidine—Sweating—Epirubicin—pancreatic cancer	0.000414	0.00202	CcSEcCtD
Nizatidine—Asthenia—Gemcitabine—pancreatic cancer	0.000412	0.00201	CcSEcCtD
Nizatidine—Confusional state—Docetaxel—pancreatic cancer	0.000411	0.00201	CcSEcCtD
Nizatidine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000408	0.00199	CcSEcCtD
Nizatidine—Pruritus—Gemcitabine—pancreatic cancer	0.000407	0.00199	CcSEcCtD
Nizatidine—Infection—Docetaxel—pancreatic cancer	0.000405	0.00198	CcSEcCtD
Nizatidine—Sinusitis—Epirubicin—pancreatic cancer	0.000405	0.00198	CcSEcCtD
Nizatidine—Diarrhoea—Irinotecan—pancreatic cancer	0.000404	0.00197	CcSEcCtD
Nizatidine—Pneumonia—Doxorubicin—pancreatic cancer	0.000401	0.00196	CcSEcCtD
Nizatidine—Pruritus—Fluorouracil—pancreatic cancer	0.0004	0.00195	CcSEcCtD
Nizatidine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000399	0.00195	CcSEcCtD
Nizatidine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000393	0.00192	CcSEcCtD
Nizatidine—Dizziness—Irinotecan—pancreatic cancer	0.00039	0.00191	CcSEcCtD
Nizatidine—Jaundice—Doxorubicin—pancreatic cancer	0.000389	0.0019	CcSEcCtD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.000389	0.00441	CbGpPWpGaD
Nizatidine—Anorexia—Docetaxel—pancreatic cancer	0.000389	0.0019	CcSEcCtD
Nizatidine—Rhinitis—Epirubicin—pancreatic cancer	0.000388	0.0019	CcSEcCtD
Nizatidine—Hepatitis—Epirubicin—pancreatic cancer	0.000387	0.00189	CcSEcCtD
Nizatidine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000387	0.00189	CcSEcCtD
Nizatidine—Pharyngitis—Epirubicin—pancreatic cancer	0.000384	0.00188	CcSEcCtD
Nizatidine—Sweating—Doxorubicin—pancreatic cancer	0.000383	0.00187	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—SCT—pancreatic cancer	0.00038	0.00431	CbGpPWpGaD
Nizatidine—Vomiting—Irinotecan—pancreatic cancer	0.000375	0.00183	CcSEcCtD
Nizatidine—Sinusitis—Doxorubicin—pancreatic cancer	0.000374	0.00183	CcSEcCtD
Nizatidine—Dizziness—Fluorouracil—pancreatic cancer	0.000374	0.00182	CcSEcCtD
Nizatidine—Rash—Irinotecan—pancreatic cancer	0.000372	0.00182	CcSEcCtD
Nizatidine—Dermatitis—Irinotecan—pancreatic cancer	0.000372	0.00181	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000372	0.00181	CcSEcCtD
Nizatidine—Headache—Irinotecan—pancreatic cancer	0.00037	0.0018	CcSEcCtD
Nizatidine—Insomnia—Docetaxel—pancreatic cancer	0.000369	0.0018	CcSEcCtD
Nizatidine—Vomiting—Gemcitabine—pancreatic cancer	0.000365	0.00178	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—CCK—pancreatic cancer	0.000363	0.00411	CbGpPWpGaD
Nizatidine—Somnolence—Docetaxel—pancreatic cancer	0.000363	0.00177	CcSEcCtD
Nizatidine—Rash—Gemcitabine—pancreatic cancer	0.000362	0.00177	CcSEcCtD
Nizatidine—Dermatitis—Gemcitabine—pancreatic cancer	0.000362	0.00177	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.000361	0.00409	CbGpPWpGaD
Nizatidine—Headache—Gemcitabine—pancreatic cancer	0.00036	0.00176	CcSEcCtD
Nizatidine—Vomiting—Fluorouracil—pancreatic cancer	0.000359	0.00175	CcSEcCtD
Nizatidine—Rhinitis—Doxorubicin—pancreatic cancer	0.000359	0.00175	CcSEcCtD
Nizatidine—Dyspepsia—Docetaxel—pancreatic cancer	0.000359	0.00175	CcSEcCtD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.000358	0.00406	CbGpPWpGaD
Nizatidine—Hepatitis—Doxorubicin—pancreatic cancer	0.000358	0.00175	CcSEcCtD
Nizatidine—Rash—Fluorouracil—pancreatic cancer	0.000356	0.00174	CcSEcCtD
Nizatidine—Dermatitis—Fluorouracil—pancreatic cancer	0.000356	0.00174	CcSEcCtD
Nizatidine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000356	0.00174	CcSEcCtD
Nizatidine—Decreased appetite—Docetaxel—pancreatic cancer	0.000355	0.00173	CcSEcCtD
Nizatidine—Headache—Fluorouracil—pancreatic cancer	0.000354	0.00173	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—CNR2—pancreatic cancer	0.000354	0.00401	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—GLP1R—pancreatic cancer	0.000354	0.00401	CbGpPWpGaD
Nizatidine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000352	0.00172	CcSEcCtD
Nizatidine—Nausea—Irinotecan—pancreatic cancer	0.00035	0.00171	CcSEcCtD
Nizatidine—Pain—Docetaxel—pancreatic cancer	0.000349	0.0017	CcSEcCtD
Nizatidine—Constipation—Docetaxel—pancreatic cancer	0.000349	0.0017	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—CCKAR—pancreatic cancer	0.000348	0.00394	CbGpPWpGaD
Nizatidine—Nausea—Gemcitabine—pancreatic cancer	0.000341	0.00167	CcSEcCtD
Nizatidine—BCHE—Metabolism of proteins—FUT8—pancreatic cancer	0.00034	0.00385	CbGpPWpGaD
Nizatidine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000336	0.00164	CcSEcCtD
Nizatidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000336	0.00381	CbGpPWpGaD
Nizatidine—Nausea—Fluorouracil—pancreatic cancer	0.000336	0.00164	CcSEcCtD
Nizatidine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000334	0.00163	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000333	0.00378	CbGpPWpGaD
Nizatidine—Flatulence—Epirubicin—pancreatic cancer	0.000332	0.00162	CcSEcCtD
Nizatidine—Tension—Epirubicin—pancreatic cancer	0.000331	0.00162	CcSEcCtD
Nizatidine—Nervousness—Epirubicin—pancreatic cancer	0.000327	0.0016	CcSEcCtD
Nizatidine—Back pain—Epirubicin—pancreatic cancer	0.000326	0.00159	CcSEcCtD
Nizatidine—Abdominal pain—Docetaxel—pancreatic cancer	0.000322	0.00157	CcSEcCtD
Nizatidine—Body temperature increased—Docetaxel—pancreatic cancer	0.000322	0.00157	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—SHH—pancreatic cancer	0.000317	0.0036	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PRLHR—pancreatic cancer	0.000316	0.00358	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—IAPP—pancreatic cancer	0.000313	0.00355	CbGpPWpGaD
Nizatidine—Anaemia—Epirubicin—pancreatic cancer	0.000312	0.00152	CcSEcCtD
Nizatidine—Flatulence—Doxorubicin—pancreatic cancer	0.000307	0.0015	CcSEcCtD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.000307	0.00348	CbGpPWpGaD
Nizatidine—Tension—Doxorubicin—pancreatic cancer	0.000306	0.00149	CcSEcCtD
Nizatidine—Nervousness—Doxorubicin—pancreatic cancer	0.000303	0.00148	CcSEcCtD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000302	0.00342	CbGpPWpGaD
Nizatidine—Back pain—Doxorubicin—pancreatic cancer	0.000302	0.00147	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—PTHLH—pancreatic cancer	0.000301	0.00341	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—PTCH1—pancreatic cancer	0.000301	0.00341	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000296	0.00335	CbGpPWpGaD
Nizatidine—Cough—Epirubicin—pancreatic cancer	0.000294	0.00144	CcSEcCtD
Nizatidine—Asthenia—Docetaxel—pancreatic cancer	0.000293	0.00143	CcSEcCtD
Nizatidine—Convulsion—Epirubicin—pancreatic cancer	0.000292	0.00143	CcSEcCtD
Nizatidine—HRH2—Signaling Pathways—GDI1—pancreatic cancer	0.00029	0.00328	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GDI2—pancreatic cancer	0.00029	0.00328	CbGpPWpGaD
Nizatidine—Pruritus—Docetaxel—pancreatic cancer	0.000289	0.00141	CcSEcCtD
Nizatidine—Anaemia—Doxorubicin—pancreatic cancer	0.000288	0.00141	CcSEcCtD
Nizatidine—Myalgia—Epirubicin—pancreatic cancer	0.000287	0.0014	CcSEcCtD
Nizatidine—Chest pain—Epirubicin—pancreatic cancer	0.000287	0.0014	CcSEcCtD
Nizatidine—Anxiety—Epirubicin—pancreatic cancer	0.000286	0.0014	CcSEcCtD
Nizatidine—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	0.000285	0.00323	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.000284	0.00322	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000284	0.00322	CbGpPWpGaD
Nizatidine—Dry mouth—Epirubicin—pancreatic cancer	0.000281	0.00137	CcSEcCtD
Nizatidine—Diarrhoea—Docetaxel—pancreatic cancer	0.000279	0.00136	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—PPY—pancreatic cancer	0.000278	0.00315	CbGpPWpGaD
Nizatidine—Confusional state—Epirubicin—pancreatic cancer	0.000277	0.00135	CcSEcCtD
Nizatidine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000275	0.00134	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—SST—pancreatic cancer	0.000275	0.00312	CbGpPWpGaD
Nizatidine—Infection—Epirubicin—pancreatic cancer	0.000273	0.00133	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000273	0.0031	CbGpPWpGaD
Nizatidine—Cough—Doxorubicin—pancreatic cancer	0.000272	0.00133	CcSEcCtD
Nizatidine—Convulsion—Doxorubicin—pancreatic cancer	0.00027	0.00132	CcSEcCtD
Nizatidine—Dizziness—Docetaxel—pancreatic cancer	0.00027	0.00132	CcSEcCtD
Nizatidine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000269	0.00132	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—SSTR3—pancreatic cancer	0.000269	0.00305	CbGpPWpGaD
Nizatidine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000266	0.0013	CcSEcCtD
Nizatidine—Myalgia—Doxorubicin—pancreatic cancer	0.000266	0.0013	CcSEcCtD
Nizatidine—Chest pain—Doxorubicin—pancreatic cancer	0.000266	0.0013	CcSEcCtD
Nizatidine—Anxiety—Doxorubicin—pancreatic cancer	0.000265	0.00129	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000264	0.00299	CbGpPWpGaD
Nizatidine—Anorexia—Epirubicin—pancreatic cancer	0.000262	0.00128	CcSEcCtD
Nizatidine—Dry mouth—Doxorubicin—pancreatic cancer	0.00026	0.00127	CcSEcCtD
Nizatidine—Vomiting—Docetaxel—pancreatic cancer	0.000259	0.00127	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—SSTR1—pancreatic cancer	0.000258	0.00292	CbGpPWpGaD
Nizatidine—Rash—Docetaxel—pancreatic cancer	0.000257	0.00126	CcSEcCtD
Nizatidine—Dermatitis—Docetaxel—pancreatic cancer	0.000257	0.00125	CcSEcCtD
Nizatidine—Confusional state—Doxorubicin—pancreatic cancer	0.000257	0.00125	CcSEcCtD
Nizatidine—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000256	0.0029	CbGpPWpGaD
Nizatidine—Headache—Docetaxel—pancreatic cancer	0.000256	0.00125	CcSEcCtD
Nizatidine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000255	0.00124	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—CNR1—pancreatic cancer	0.000254	0.00288	CbGpPWpGaD
Nizatidine—Infection—Doxorubicin—pancreatic cancer	0.000253	0.00123	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—PPY—pancreatic cancer	0.000253	0.00286	CbGpPWpGaD
Nizatidine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000251	0.00122	CcSEcCtD
Nizatidine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000249	0.00122	CcSEcCtD
Nizatidine—Insomnia—Epirubicin—pancreatic cancer	0.000249	0.00121	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—SSTR2—pancreatic cancer	0.000248	0.00281	CbGpPWpGaD
Nizatidine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000246	0.0012	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—GCG—pancreatic cancer	0.000245	0.00278	CbGpPWpGaD
Nizatidine—Somnolence—Epirubicin—pancreatic cancer	0.000245	0.00119	CcSEcCtD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	0.000243	0.00276	CbGpPWpGaD
Nizatidine—Anorexia—Doxorubicin—pancreatic cancer	0.000243	0.00118	CcSEcCtD
Nizatidine—Nausea—Docetaxel—pancreatic cancer	0.000242	0.00118	CcSEcCtD
Nizatidine—Dyspepsia—Epirubicin—pancreatic cancer	0.000242	0.00118	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—CCKBR—pancreatic cancer	0.000239	0.00271	CbGpPWpGaD
Nizatidine—Decreased appetite—Epirubicin—pancreatic cancer	0.000239	0.00117	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000238	0.00116	CcSEcCtD
Nizatidine—Constipation—Epirubicin—pancreatic cancer	0.000235	0.00115	CcSEcCtD
Nizatidine—Pain—Epirubicin—pancreatic cancer	0.000235	0.00115	CcSEcCtD
Nizatidine—HRH2—GPCR ligand binding—AGTR1—pancreatic cancer	0.000234	0.00265	CbGpPWpGaD
Nizatidine—BCHE—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.000233	0.00264	CbGpPWpGaD
Nizatidine—BCHE—Phospholipid metabolism—PIK3CG—pancreatic cancer	0.000233	0.00264	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	0.000232	0.00264	CbGpPWpGaD
Nizatidine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000232	0.00113	CcSEcCtD
Nizatidine—Insomnia—Doxorubicin—pancreatic cancer	0.00023	0.00112	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—GAST—pancreatic cancer	0.000227	0.00257	CbGpPWpGaD
Nizatidine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000227	0.00111	CcSEcCtD
Nizatidine—Somnolence—Doxorubicin—pancreatic cancer	0.000226	0.0011	CcSEcCtD
Nizatidine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000225	0.0011	CcSEcCtD
Nizatidine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000224	0.00109	CcSEcCtD
Nizatidine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000221	0.00108	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00022	0.00107	CcSEcCtD
Nizatidine—Urticaria—Epirubicin—pancreatic cancer	0.000219	0.00107	CcSEcCtD
Nizatidine—Constipation—Doxorubicin—pancreatic cancer	0.000218	0.00106	CcSEcCtD
Nizatidine—Pain—Doxorubicin—pancreatic cancer	0.000218	0.00106	CcSEcCtD
Nizatidine—Body temperature increased—Epirubicin—pancreatic cancer	0.000217	0.00106	CcSEcCtD
Nizatidine—Abdominal pain—Epirubicin—pancreatic cancer	0.000217	0.00106	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—SCT—pancreatic cancer	0.000215	0.00244	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000213	0.00241	CbGpPWpGaD
Nizatidine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00021	0.00102	CcSEcCtD
Nizatidine—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000209	0.00237	CbGpPWpGaD
Nizatidine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000208	0.00102	CcSEcCtD
Nizatidine—BCHE—Metabolism of proteins—PCSK1—pancreatic cancer	0.000208	0.00235	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—GAST—pancreatic cancer	0.000206	0.00233	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CCK—pancreatic cancer	0.000205	0.00232	CbGpPWpGaD
Nizatidine—BCHE—Phospholipid metabolism—PIK3CD—pancreatic cancer	0.000205	0.00232	CbGpPWpGaD
Nizatidine—Urticaria—Doxorubicin—pancreatic cancer	0.000202	0.000987	CcSEcCtD
Nizatidine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000201	0.000983	CcSEcCtD
Nizatidine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000201	0.000983	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—CNR2—pancreatic cancer	0.0002	0.00227	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.0002	0.00227	CbGpPWpGaD
Nizatidine—Asthenia—Epirubicin—pancreatic cancer	0.000197	0.000964	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000197	0.00223	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—SCT—pancreatic cancer	0.000195	0.00221	CbGpPWpGaD
Nizatidine—Pruritus—Epirubicin—pancreatic cancer	0.000195	0.00095	CcSEcCtD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000191	0.00216	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.00019	0.00215	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000188	0.00214	CbGpPWpGaD
Nizatidine—Diarrhoea—Epirubicin—pancreatic cancer	0.000188	0.000919	CcSEcCtD
Nizatidine—HRH2—Signaling Pathways—PRLHR—pancreatic cancer	0.000187	0.00212	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CCK—pancreatic cancer	0.000186	0.00211	CbGpPWpGaD
Nizatidine—Asthenia—Doxorubicin—pancreatic cancer	0.000183	0.000892	CcSEcCtD
Nizatidine—Dizziness—Epirubicin—pancreatic cancer	0.000182	0.000888	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—CNR2—pancreatic cancer	0.000181	0.00206	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000181	0.00206	CbGpPWpGaD
Nizatidine—Pruritus—Doxorubicin—pancreatic cancer	0.00018	0.000879	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000179	0.00202	CbGpPWpGaD
Nizatidine—BCHE—Phospholipid metabolism—PIK3CB—pancreatic cancer	0.000178	0.00202	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000177	0.00201	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000176	0.00199	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000176	0.00199	CbGpPWpGaD
Nizatidine—Vomiting—Epirubicin—pancreatic cancer	0.000175	0.000854	CcSEcCtD
Nizatidine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000174	0.00085	CcSEcCtD
Nizatidine—Rash—Epirubicin—pancreatic cancer	0.000173	0.000847	CcSEcCtD
Nizatidine—Dermatitis—Epirubicin—pancreatic cancer	0.000173	0.000846	CcSEcCtD
Nizatidine—Headache—Epirubicin—pancreatic cancer	0.000172	0.000842	CcSEcCtD
Nizatidine—HRH2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00017	0.00193	CbGpPWpGaD
Nizatidine—Dizziness—Doxorubicin—pancreatic cancer	0.000168	0.000822	CcSEcCtD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000165	0.00187	CbGpPWpGaD
Nizatidine—Nausea—Epirubicin—pancreatic cancer	0.000163	0.000798	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—SHH—pancreatic cancer	0.000163	0.00185	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000162	0.00184	CbGpPWpGaD
Nizatidine—Vomiting—Doxorubicin—pancreatic cancer	0.000162	0.00079	CcSEcCtD
Nizatidine—HRH2—Signaling by GPCR—IAPP—pancreatic cancer	0.000161	0.00182	CbGpPWpGaD
Nizatidine—Rash—Doxorubicin—pancreatic cancer	0.000161	0.000784	CcSEcCtD
Nizatidine—Dermatitis—Doxorubicin—pancreatic cancer	0.00016	0.000783	CcSEcCtD
Nizatidine—Headache—Doxorubicin—pancreatic cancer	0.000159	0.000779	CcSEcCtD
Nizatidine—HRH2—Signaling Pathways—DTX1—pancreatic cancer	0.000159	0.0018	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SSTR3—pancreatic cancer	0.000159	0.0018	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—SST—pancreatic cancer	0.000155	0.00176	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000154	0.00175	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000154	0.00175	CbGpPWpGaD
Nizatidine—BCHE—Phospholipid metabolism—PTEN—pancreatic cancer	0.000154	0.00175	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SSTR1—pancreatic cancer	0.000152	0.00172	CbGpPWpGaD
Nizatidine—Nausea—Doxorubicin—pancreatic cancer	0.000151	0.000738	CcSEcCtD
Nizatidine—HRH2—Signaling Pathways—PPY—pancreatic cancer	0.000149	0.00169	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SSTR2—pancreatic cancer	0.000146	0.00166	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000143	0.00163	CbGpPWpGaD
Nizatidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	0.000143	0.00162	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCKBR—pancreatic cancer	0.000141	0.0016	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—SST—pancreatic cancer	0.000141	0.0016	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000141	0.00159	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000139	0.00157	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—GCG—pancreatic cancer	0.000139	0.00157	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—DTX4—pancreatic cancer	0.000133	0.00151	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GLI1—pancreatic cancer	0.000133	0.00151	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PRSS1—pancreatic cancer	0.000133	0.0015	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000132	0.0015	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	0.000131	0.00148	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CNR1—pancreatic cancer	0.00013	0.00148	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000129	0.00147	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NRP1—pancreatic cancer	0.000129	0.00147	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—GCG—pancreatic cancer	0.000126	0.00143	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000125	0.00142	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	0.000125	0.00142	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HEY2—pancreatic cancer	0.000125	0.00141	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	0.000122	0.00139	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GAST—pancreatic cancer	0.000122	0.00138	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000121	0.00138	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—AGTR1—pancreatic cancer	0.00012	0.00136	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000119	0.00135	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SCT—pancreatic cancer	0.000115	0.00131	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HEY1—pancreatic cancer	0.000115	0.00131	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ARG2—pancreatic cancer	0.000115	0.0013	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCK—pancreatic cancer	0.00011	0.00125	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—GCG—pancreatic cancer	0.000109	0.00124	CbGpPWpGaD
Nizatidine—BCHE—Phospholipid metabolism—PIK3CA—pancreatic cancer	0.000109	0.00123	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CNR2—pancreatic cancer	0.000107	0.00122	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GLP1R—pancreatic cancer	0.000107	0.00122	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000107	0.00121	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	0.000106	0.0012	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCKAR—pancreatic cancer	0.000105	0.0012	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—JAG2—pancreatic cancer	0.000102	0.00116	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MEN1—pancreatic cancer	0.000101	0.00114	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—TYMP—pancreatic cancer	0.000101	0.00114	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	9.74e-05	0.0011	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SHH—pancreatic cancer	9.62e-05	0.00109	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOTCH4—pancreatic cancer	9.56e-05	0.00108	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IAPP—pancreatic cancer	9.5e-05	0.00108	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PTHLH—pancreatic cancer	9.12e-05	0.00103	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PTCH1—pancreatic cancer	9.12e-05	0.00103	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	9.09e-05	0.00103	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	9.04e-05	0.00102	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	8.65e-05	0.000981	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SST—pancreatic cancer	8.34e-05	0.000945	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.3e-05	0.000941	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.22e-05	0.000932	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—JAG1—pancreatic cancer	8.16e-05	0.000925	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOTCH3—pancreatic cancer	8.13e-05	0.000921	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GLP1R—pancreatic cancer	8.11e-05	0.000919	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—DPYD—pancreatic cancer	7.98e-05	0.000904	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.89e-05	0.000894	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	7.82e-05	0.000886	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CNR1—pancreatic cancer	7.69e-05	0.000872	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—SLC2A2—pancreatic cancer	7.57e-05	0.000858	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.49e-05	0.000849	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	7.47e-05	0.000847	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CG—pancreatic cancer	7.47e-05	0.000846	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—GCG—pancreatic cancer	7.43e-05	0.000842	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.23e-05	0.00082	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.23e-05	0.000819	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—AGTR1—pancreatic cancer	7.09e-05	0.000804	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—STK11—pancreatic cancer	6.99e-05	0.000792	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	6.65e-05	0.000753	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.59e-05	0.000746	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CD—pancreatic cancer	6.56e-05	0.000744	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PRSS1—pancreatic cancer	6.48e-05	0.000734	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.3e-05	0.000714	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	6.17e-05	0.000699	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SMAD4—pancreatic cancer	6.12e-05	0.000694	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CXCL8—pancreatic cancer	6.06e-05	0.000686	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	6e-05	0.000681	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HES1—pancreatic cancer	5.98e-05	0.000677	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	5.95e-05	0.000674	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CD44—pancreatic cancer	5.86e-05	0.000664	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	5.8e-05	0.000657	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.74e-05	0.000651	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	5.74e-05	0.00065	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—HRAS—pancreatic cancer	5.73e-05	0.000649	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CB—pancreatic cancer	5.72e-05	0.000649	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.69e-05	0.000645	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GCG—pancreatic cancer	5.62e-05	0.000637	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ARG2—pancreatic cancer	5.62e-05	0.000636	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CXCL8—pancreatic cancer	5.5e-05	0.000623	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	5.37e-05	0.000609	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—STK11—pancreatic cancer	5.28e-05	0.000599	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TERT—pancreatic cancer	5.24e-05	0.000593	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	5.24e-05	0.000593	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HIF1A—pancreatic cancer	5.01e-05	0.000568	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TSC2—pancreatic cancer	4.99e-05	0.000566	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.96e-05	0.000562	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—TYMP—pancreatic cancer	4.91e-05	0.000556	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—APOE—pancreatic cancer	4.89e-05	0.000554	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	4.82e-05	0.000546	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	4.8e-05	0.000545	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KDR—pancreatic cancer	4.79e-05	0.000543	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	4.77e-05	0.00054	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	4.71e-05	0.000534	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NFKBIA—pancreatic cancer	4.55e-05	0.000516	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—TYMS—pancreatic cancer	4.55e-05	0.000515	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NOTCH1—pancreatic cancer	4.51e-05	0.000511	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.49e-05	0.000509	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.45e-05	0.000504	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CG—pancreatic cancer	4.41e-05	0.0005	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—NRAS—pancreatic cancer	4.41e-05	0.0005	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	4.4e-05	0.000498	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EGF—pancreatic cancer	4.36e-05	0.000494	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.09e-05	0.000463	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—EGFR—pancreatic cancer	4.02e-05	0.000456	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GLP1R—pancreatic cancer	3.96e-05	0.000448	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.96e-05	0.000448	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—DPYD—pancreatic cancer	3.89e-05	0.000441	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CD—pancreatic cancer	3.88e-05	0.00044	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.84e-05	0.000435	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—KRAS—pancreatic cancer	3.8e-05	0.00043	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—APOE—pancreatic cancer	3.7e-05	0.000419	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	3.69e-05	0.000419	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.5e-05	0.000397	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.49e-05	0.000395	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CB—pancreatic cancer	3.38e-05	0.000383	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.34e-05	0.000379	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CG—pancreatic cancer	3.34e-05	0.000378	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CXCL8—pancreatic cancer	3.25e-05	0.000368	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—HRAS—pancreatic cancer	3.23e-05	0.000366	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PPARG—pancreatic cancer	3.22e-05	0.000365	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—AKT1—pancreatic cancer	3.14e-05	0.000356	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CASP3—pancreatic cancer	3.11e-05	0.000352	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CCND1—pancreatic cancer	3.03e-05	0.000343	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CTNNB1—pancreatic cancer	3e-05	0.00034	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MMP9—pancreatic cancer	2.94e-05	0.000333	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CD—pancreatic cancer	2.93e-05	0.000332	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PTEN—pancreatic cancer	2.92e-05	0.000331	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CD44—pancreatic cancer	2.86e-05	0.000324	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—AKT1—pancreatic cancer	2.85e-05	0.000323	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GCG—pancreatic cancer	2.74e-05	0.000311	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SRC—pancreatic cancer	2.71e-05	0.000307	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—VEGFA—pancreatic cancer	2.64e-05	0.000299	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—STAT3—pancreatic cancer	2.61e-05	0.000296	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NRAS—pancreatic cancer	2.61e-05	0.000295	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—STK11—pancreatic cancer	2.58e-05	0.000292	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CB—pancreatic cancer	2.56e-05	0.00029	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PTGS2—pancreatic cancer	2.53e-05	0.000287	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MYC—pancreatic cancer	2.43e-05	0.000275	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TGFB1—pancreatic cancer	2.42e-05	0.000274	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EGFR—pancreatic cancer	2.37e-05	0.000269	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KRAS—pancreatic cancer	2.24e-05	0.000254	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—TYMS—pancreatic cancer	2.22e-05	0.000251	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PTEN—pancreatic cancer	2.21e-05	0.00025	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PIK3CA—pancreatic cancer	2.06e-05	0.000234	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TP53—pancreatic cancer	1.99e-05	0.000226	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HRAS—pancreatic cancer	1.91e-05	0.000216	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—APOE—pancreatic cancer	1.8e-05	0.000204	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—AKT1—pancreatic cancer	1.68e-05	0.000191	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.63e-05	0.000185	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PPARG—pancreatic cancer	1.57e-05	0.000178	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PIK3CA—pancreatic cancer	1.56e-05	0.000177	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.43e-05	0.000162	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—AKT1—pancreatic cancer	1.27e-05	0.000144	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.25e-05	0.000141	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.24e-05	0.00014	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PTEN—pancreatic cancer	1.08e-05	0.000122	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	7.6e-06	8.62e-05	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—AKT1—pancreatic cancer	6.21e-06	7.04e-05	CbGpPWpGaD
